After Some Hostilities, Glaxo Agrees To Buy HGS For $3.6B
- Tuesday, July 17, 2012, 2:53
- Market
- Add a comment
Ending the tug-of-war between the two companies, the boards of GlaxoSmithKline (GSK) and Human Genome Sciences (HGS) agreed on a transaction price. On Monday, HGS announced it agreed to a $14.25 per share offer by GSK, valuing the company at about $3.6 billion; after an initial refusal by HGS, GSK pursued a hostile takeover of the company, but eventually upped their offer and closed the deal on friendly terms.
http://www.forbes.com/sites/afontevecchia/2012/07/16/after-some-hostilities-glaxo-agrees-to-buy-hgs-for-3-6b/
About the Author
admin123 has written 23412 stories on this site.
